Showing results (21-30 of 28) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 28 results.
The Journal of Craniofacial Surgery|February 19, 2021
Postoperative Clinical Outcomes Using Standard Variables Following Levator-Mullerectomy Advancement Blepharoptosis SurgeryStephen C Dryden, Jonathan E Rho, Samuel C Fowler, et al.
Eplasty|June 7, 2024
Intraosseous Hemangioma of the Zygomatic Bone with Multidisciplinary Approach to Surgical Resection and Orbital ReconstructionAlisa L Phillips, Meredith A Allen, Fabliha A Mukit, et al.
Optometry and Vision Science : Official Publication of the American Academy of Optometry|December 9, 2021
Opioid Prescribing Patterns of Optometrists in the Medicare Part D DatabaseStephen C Dryden, Holly A O'Malley, Lindsey R Adams, et al.
Cureus|May 29, 2024
The Diagnostic Accuracy of First-Year Ophthalmology Residents on Call: Considerations for Postgraduate Year 2 (PGY-2) Standardizations of Call StructureMarium Hashemi, Shawyon C Rohani, Fabliha A Mukit, et al.
Orbit (Amsterdam, Netherlands)|September 13, 2021
Long-acting opioid prescribing patterns of ophthalmic plastic surgeons in the medicare Part D databaseStephen C Dryden, Jonathan E Rho, Garrett C Nix, et al.
The Journal of Clinical Endocrinology and Metabolism|November 5, 2023
Efficacy and Safety of Teprotumumab in Patients With Thyroid Eye Disease of Long Duration and Low Disease ActivityRaymond S Douglas, Steven Couch, Sara T Wester, et al.
Ophthalmology|October 24, 2021
Teprotumumab Efficacy, Safety, and Durability in Longer-Duration Thyroid Eye Disease and Re-treatment: OPTIC-X StudyRaymond S Douglas, George J Kahaly, Shoaib Ugradar, et al.
The New England Journal of Medicine|January 24, 2020
Teprotumumab for the Treatment of Active Thyroid Eye DiseaseRaymond S Douglas, George J Kahaly, Amy Patel, et al.
Pageof 3